BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 16372223)

  • 1. Diagnosis and management of tumors of the adrenal medulla.
    Ilias I; Pacak K
    Horm Metab Res; 2005 Dec; 37(12):717-21. PubMed ID: 16372223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pheochromocytoma: diagnostic and therapeutic update.
    Oleaga A; Goñi F
    Endocrinol Nutr; 2008 May; 55(5):202-16. PubMed ID: 22967914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, localization and treatment of pheochromocytoma in MEN 2 syndrome.
    Ilias I; Pacak K
    Endocr Regul; 2009 Apr; 43(2):89-93. PubMed ID: 19856714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour.
    Pacak K; Ilias I; Adams KT; Eisenhofer G
    J Intern Med; 2005 Jan; 257(1):60-8. PubMed ID: 15606377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytoma: presentation, diagnosis and treatment.
    Reisch N; Peczkowska M; Januszewicz A; Neumann HP
    J Hypertens; 2006 Dec; 24(12):2331-9. PubMed ID: 17082709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytomas and secreting paragangliomas.
    Plouin PF; Gimenez-Roqueplo AP
    Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas.
    Ilias I; Shulkin B; Pacak K
    Trends Endocrinol Metab; 2005 Mar; 16(2):66-72. PubMed ID: 15734147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personal experience in diagnosis and localization of pheochromocytoma].
    Andjelković Z; Tavcar I
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to detect pheochromocytomas?--the diagnostic relevance of plasma free metanephrines.
    Roden M
    Wien Klin Wochenschr; 2002 Apr; 114(7):246-51. PubMed ID: 12089859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic and therapeutic procedures in pheochromocytoma: current trends].
    Widimský J; Zelinka T; Petrák O; Strauch B; Safarík L; Kasalický M; Vranková A; Holaj R
    Vnitr Lek; 2007 Apr; 53(4):428-33. PubMed ID: 17578179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paragangliomas: etiology, presentation, and management.
    Joynt KE; Moslehi JJ; Baughman KL
    Cardiol Rev; 2009; 17(4):159-64. PubMed ID: 19525677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
    Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
    J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The sympathetic system and neuroendocrine hypertension].
    Zuccala' A; Di Nicolo' P; Fiorenza S; Lifrieri F; Rapana' R
    G Ital Nefrol; 2008; 25(2):203-14. PubMed ID: 18350500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in diagnosis and treatment of pheochromocytoma.
    Veglio F; Morello F; Morra Di Cella S; Del Colle S; Rabbia F; Mulatero P
    Minerva Med; 2003 Aug; 94(4):267-71. PubMed ID: 14605591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach.
    Andersen KF; Altaf R; Krarup-Hansen A; Kromann-Andersen B; Horn T; Christensen NJ; Hendel HW
    Cancer Treat Rev; 2011 Apr; 37(2):111-9. PubMed ID: 20675056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
    Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
    N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and therapy of neuroectodermal tumors].
    Adolph J; Kimmig B
    Radiologe; 1989 Jan; 29(1):32-42. PubMed ID: 2537501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
    Kaji P; Carrasquillo JA; Linehan WM; Chen CC; Eisenhofer G; Pinto PA; Lai EW; Pacak K
    Eur J Endocrinol; 2007 Apr; 156(4):483-7. PubMed ID: 17389464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear medicine therapy of pheochromocytoma and paraganglioma.
    Troncone L; Rufini V
    Q J Nucl Med; 1999 Dec; 43(4):344-55. PubMed ID: 10731785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.